Anas El Turabi

Anas El Turabi

Auto-generated profile, based on publicly available information

Anas El Turabi

Harvard University, Cambridge, MA, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2013 in BMJ Open
Verified
Journal Article
Open access
PDF file
CSCatherine L Saunders
Catherine L Saunders
GAGary Abel
Gary Abel
ATA El Turabi
A El Turabi
FAFaraz Ahmed
Faraz Ahmed
GLGeorgios Lyratzopoulos
Georgios Lyratzopoulos
Objective To describe the accuracy of ethnicity coding in contemporary National Health Service (NHS) hospital records compared with the ‘gold standard’ of self-reported ethnicity. Design Secondary analysis of data from a cross-sectional survey (2011). Setting All NHS hospitals in England providing cancer treatment. Participants 58 721 patients with cancer for whom ethnicity information (Office for National Statistics 2001 16-group classification) was available from self-reports (considered to represent the ‘gold standard’) and their hospital record. Methods We calculated the sensitivity and positive predictive value (PPV) of hospital record ethnicity. Further, we used a logistic regression model to explore independent predictors of discordance between recorded and self-reported ethnicity. Results Overall, 4.9% (4.7–5.1%) of people had their self-reported ethnic group incorrectly recorded in their hospital records. Recorded White British ethnicity had high sensitivity (97.8% (97.7–98.0%)) and PPV (98.1% (98.0–98.2%)) for self-reported White British ethnicity. Recorded ethnicity information for the 15 other ethnic groups was substantially less accurate with 41.2% (39.7–42.7%) incorrect. Recorded ‘Mixed’ ethnicity had low sensitivity (12–31%) and PPVs (12–42%). Recorded ‘Indian’, ‘Chinese’, ‘Black-Caribbean’ and ‘Black African’ ethnic groups had intermediate levels of sensitivity (65–80%) and PPV (80–89%, respectively). In multivariable analysis, belonging to an ethnic minority group was the only independent predictor of discordant ethnicity information. There was strong evidence that the degree of discordance of ethnicity information varied substantially between different hospitals (p<0.0001). Discussion Current levels of accuracy of ethnicity information in NHS hospital records support valid profiling of White/non-White ethnic differences. However, profiling of ethnic differences in process or outcome measures for specific minority groups may contain a substantial and variable degree of misclassification error. These considerations should be taken into account when interpreting ethnic variation audits based on routine data and inform initiatives aimed at improving the accuracy of ethnicity information in hospital records.

1 November 2016 in The Lancet
Verified
Journal Article
Closed access
PSPeter Sands
Peter Sands
ATAnas El Turabi
Anas El Turabi
PSPhilip A Saynisch
Philip A Saynisch
VDVictor J Dzau
Victor J Dzau

27 June 2013 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
ATA El Turabi
A El Turabi
GAGary Abel
Gary Abel
MRM Roland
M Roland
GLGeorgios Lyratzopoulos
Georgios Lyratzopoulos
Background: Exploring variation in patients’ experiences of involvement in treatment decision making can identify groups needing extra support, such as additional consultation time, when considering treatment options. Methods: We analysed data from the 2010 English National Cancer Patient Experience Survey, a national survey of all patients attending hospitals in England for cancer treatment over a 3-month period, to examine how experience of involvement in decisions about treatment varied between patients with 38 different primary cancers using logistic regression. We analysed responses from 41 411 patients to a single question examining patient experience of involvement in treatment decision making. We calculated unadjusted odds ratios of reporting the most positive experience between patients of different sociodemographic and tumour characteristics and explored the effects of adjusting for age, gender, ethnicity, deprivation, cancer type and hospital of treatment. Results: Of the 41 441 respondents, 29 776 (72%) reported positive experiences of decision-making involvement. Younger patients reported substantially less positive experiences of involvement in decision making (adjusted OR=0.49 16–24 vs 65–74; P<0.001), as did ethnic minorities (adjusted ORs=0.52, 0.62 and 0.73 for Black, Chinese and Asian vs White patients, respectively; P<0.001). Experience varied considerably between patients with different cancers ( e.g., OR=0.52 for anal and 1.37 for melanoma vs colon cancer; P<0.001), with ovarian, myeloma, bladder and rectal cancer patients reporting substantially worse experiences compared with other patients with gynaecological, haematological, urological and colorectal cancers, respectively. Clustering of different patient groups within hospitals with outlying performance report scores could not account for observed differences. Conclusion: Efforts to improve involvement in treatment decision making can focus on those who report the worst experience, in particular younger patients, ethnic minorities and patients with rectal, ovarian, multiple myeloma and bladder cancer.

1 August 2017 in The Lancet Global Health
Verified
Journal Article
Open access
GYGavin Yamey
Gavin Yamey
MSMarco Schäferhoff
Marco Schäferhoff
OAOle Kristian Aars
Ole Kristian Aars
BBBarry Bloom
Barry Bloom
DCDennis Carroll
Dennis Carroll
EWEd Whiting
Ed Whiting

1 June 2017 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
CMCatherine Machalaba
Catherine Machalaba
KSKristine M Smith
Kristine M Smith
LALina Awada
Lina Awada
KBKevin Berry
Kevin Berry
FBFranck Berthe
Franck Berthe
WKWilliam B Karesh
William B Karesh
Global economic impacts of epidemics suggest high return on investment in prevention and One Health capacity. However, such investments remain limited, contributing to persistent endemic diseases and vulnerability to emerging ones. An interdisciplinary workshop explored methods for country-level analysis of added value of One Health approaches to disease control. Key recommendations include: 1. systems thinking to identify risks and mitigation options for decision-making under uncertainty; 2. multisectoral economic impact assessment to identify wider relevance and possible resource-sharing, and 3. consistent integration of environmental considerations. Economic analysis offers a congruent measure of value complementing diverse impact metrics among sectors and contexts.

17 September 2012 in BMJ
Verified
Journal Article
Closed access
PDF file
MGMuir Gray
Muir Gray
ATA. E. Turabi
A. E. Turabi
All clinician groups should estimate which interventions are most beneficial . Few big scientific ideas are so widely adopted and understood as the concept of the paradigm shift.1 Robert Brook, one of the founders of the quality improvement paradigm, in a recent article entitled, The End of the Quality Improvement Movement: Long Live Improving Value , described incisively the latest big paradigm shift that has arisen as a consequence of the economic imperatives challenging health systems globally.2 Quality, safety, and evidence of effectiveness in medical care—the previous paradigms—are still essential, but only in so far as they affect value. Consideration of value is what lies at the heart of a new report by IMPRESS (Improving and Integrating Respiratory Services)3—a collaboration between respiratory specialists and generalists with a special interest in lung health. The report calculated the relative value of different interventions within a particular system of healthcare: services for patients with chronic obstructive pulmonary disease (COPD). Value relates the outcomes of healthcare interventions to their cost. Costs are considered not only in terms of money or carbon, but …